Applied Molecular Therapies
Our goal is to help improve cancer patient outcomes with accessible, targeted radiopharmaceuticals, focussing initially on use of the radionuclide Lutetium-177. Applied Molecular Therapies (AMT) – a leader in the development, manufacture and supply of next generation therapeutic radiopharmaceuticals for cancer treatments in Australia and New Zealand. Cyclotek, a leading radiopharmaceutical manufacturer, is at the forefront of validating new molecular targeted radiopharmaceuticals for the Australian and New Zealand markets. By using accessible targeted radiopharmaceuticals, our goal is to improve cancer patient outcomes. ANSTO, Australia’s knowledge centre for nuclear science and engineering, leverages great science to deliver big outcomes.
Verified
Advanced manufacturing in Australia: Applied Molecular Therapies launches its first theranostic product in prostate cancer treatment - Applied Molecular Therapies
Applied Molecular Therapies (AMT) has announced a successful TGA licence upgrade for the GMP manufacture of an emerging prostate cancer therapy, following the launch of a new joint venture between Cyclotek and ANSTO. 177Lu(n.c.a.)-PSMA-Therapy is a molecular targeted radiopharmaceutical that binds to the PSMA (Prostate Specific Membrane Antigen) in men living with prostate cancer. Prostate […]
View all products
Keywords
Industries
Where is Applied Molecular Therapies located?
The company Applied Molecular Therapies is located in Melbourne, Victoria, Australia. It's worth noting that the company may has more corporate locations
How many employees does Applied Molecular Therapies approximately have?
As of the latest available information Applied Molecular Therapies has around 51-100 employees worldwide.
When was Applied Molecular Therapies founded?
Applied Molecular Therapies was founded in 2021
In which industries does Applied Molecular Therapies mainly work?
The company Applied Molecular Therapies has it's main focus in the industries of Pharmaceuticals
What is the current company status of Applied Molecular Therapies?
Based on the founding year and the amount of employees the company Applied Molecular Therapies seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Point Biopharma
United States
11-50 Employees
2017
View
ARTMS
Canada
11-50 Employees
2013
View
RayzeBio
United States
11-50 Employees
2018
View
Advanced Nuclear Medicine Ingredients
Belgium
11-50 Employees
2015
View
AREVA Med LLC
United States
11-50 Employees
View
Isotopia
Israel
2006
View
Fusion Pharmaceuticals
Canada
11-50 Employees
2014
View
ALPHAXRT PTY LTD
Australia
1-10 Employees
2002
View
Topics which have been searched by others and may be interesting for you:
